NCI-H929R NTCC®人骨髓瘤细胞耐药细胞株human myeloma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

NCI-H929R NTCC®人骨髓瘤细胞耐药细胞株human myeloma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

NCI-H929R is a cell line derived from the NCI-H929 cell line, which is a human myeloma cell line. The "R" in NCI-H929R likely indicates that it is a resistant cell line, meaning it has developed resistance to a specific drug or treatment, such as bortezomib.

Key Characteristics:

• Origin: Derived from the NCI-H929 human myeloma cell line.

• Resistance: Resistant to specific drugs, particularly bortezomib.

• Applications: Used in cancer research to study drug resistance mechanisms, develop new therapeutic strategies, and identify potential drug targets.

It's important to note that the specific characteristics and applications of NCI-H929R may vary depending on the specific resistance mechanism and the experimental context.

Image

生产厂家Supplier:

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

E-mail:BioVector@163.com

http://www.biovector.net